therapeutic antibodies
Singapore Patient Plasma Used To Create Trump’s COVID-19 Antibody Cocktail
The antibody cocktail used to treat US President Donald Trump was developed from patient samples from Singapore.
CStone Pharma Completes US$260 Million Series B Funding Round
The funds raised will primarily be used for clinical development of CS1001 and other clinical stage assets, as well as attract top industry talents.
Neutralizing Antibody Shields Mice From Zika Virus
A single injection of a human neutralizing antibody is enough to protect developing mouse embryos against Zika virus infection and microcephaly, researchers say.
Small, Stable Antibody Fragments Make Protein Crystallization Easier
Researchers in Japan have created a hybrid antibody fragment to aid structural determination of ‘uncrystallizable’ target proteins.
How Bunyaviruses Attack And Enter
Scientists in China have determined the structure of the a key glycoprotein in two viruses that cause febrile illnesses.
7 Must-Read Stories In June 2017
Climate change, solar energy and disease were key issues in the month of June.
Going Anti-Dengue With Antibodies
Therapeutic antibodies offer promising new options for treating infectious diseases, including dengue, writes immunologist Dr Katja Fink.
A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding
The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.
Tessa Therapeutics Completes Acquisition of Euchloe Bio
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
Two Zika Neutralizing Antibodies Found
Researchers have found two potent Zika-neutralizing antibodies that could be used as part of a therapeutic cocktail to treat patients.
